Kinetic Secure Home Named Best in Class for Partnership for Home Security
LITTLE ROCK, Ark.–(BUSINESS WIRE)–Like its predecessor Kinetic Secure, Kinetic Secure Home now is garnering industry…
Month: April 2022
Blue Yonder Named a Leader in the 2022 Gartner® Magic Quadrant™ for Transportation Management Systems Report, Positioned Furthest in Completeness of Vision for Sixth Year
Evaluation based on ability to execute and completeness of vision Blue Yonder is the only…
Nutanix Appoints Mandy Dhaliwal as Chief Marketing Officer and Shyam Desirazu as Head of Engineering
Company Adds Seasoned Experts with Track Record of Driving Growth and Innovation Across Cloud and…
SingleStore Database with IBM Now Available to Empower Customers with a One-Stop Shop
New collaboration with IBM designed to accelerate insights for data-intensive apps, while reducing latencies SAN…
Two Edge Servers from Inspur Information Win 2022 Red Dot Awards
EIS800 and Swing P101 Edge Microservers were both recognized for excellence in the Product Design…
Securiti to Present at IAPP Global Privacy Summit 2022
Case Study Session on Data-centric Approach to Privacy Management will Feature Best Practices from Chief…
Perforce Named a Leader in IDC MarketScape Report for Worldwide Cloud Testing and IDC MarketScape Report for Mobile Testing and Digital Quality
As organizations shift to testing in and for the cloud, and focus mobile quality, they…
Webcast Details for Cassava Sciences’ Upcoming Fireside Chat
– All Stakeholder Are Welcome to Listen by Webcast – – Event To Be Held…
Accumulus Synergy Announces the Appointment of New Leadership Team Members
BURLINGAME, Calif., April 04, 2022 (GLOBE NEWSWIRE) — Accumulus Synergy, a nonprofit corporation working to…
Scilex Holding Company, a majority-owned subsidiary of Sorrento Therapeutics, Inc., announces continuous sales growth in ZTlido® with preliminary gross sales of approximately $8.1 million during the month of March 2022 and $18.4 million for 1Q2022
ZTlido 53% year-over-year preliminary unaudited gross sales in March 2022 Select payor accounts representing approximately…
PacBio Enters Agricultural Industry Collaboration with Corteva Agriscience to Develop High-Throughput Plant, Pest and Microbial Sequencing
The companies will leverage high-throughput whole genome HiFi sequencing for advanced plant biotechnology, breeding and…
Castellum, Inc. Announces $950,000 New Revolving Credit Facility from Live Oak Bank
Castellum, Inc. Announces $950,000 New Revolving Credit Facility from Live Oak Bank Castellum, Inc. (OTC:…
INmune Bio, Inc. Highlights INKmune™ Data Featured in NK Cells in Solid Tumors Workshop at Innate Killer Summit
INKmune™, unlike IL15 and other NK-activating cytokines, upregulates all mitochondrial survival proteins and more than…
Dyadic International to Present at Upcoming Scientific Medical Meetings
JUPITER, Fla., April 04, 2022 (GLOBE NEWSWIRE) — Dyadic International, Inc. (“Dyadic”, or the “Company”)…
Zealand Pharma to Participate in 21st Annual Needham Virtual Healthcare Conference
Company announcement – No. 11 / 2022 Zealand Pharma to Participate in 21st Annual Needham Virtual Healthcare Conference…
Vaxcyte Doses First Participants in Phase 2 Portion of Ongoing VAX-24 Phase 1/2 Clinical Proof-of-Concept Study in Adults
— Following Prespecified Review of Phase 1 Safety and Tolerability Data, Independent Data Monitoring Committee…
eFFECTOR Therapeutics Announces Transition in Clinical Leadership
Premal Patel, M.D., Ph.D., chief medical officer, has resigned to pursue a new career opportunity…
Journey Medical Corporation to Present at the Virtual Fortress Biotech R&D Summit Hosted by B. Riley Securities
SCOTTSDALE, Ariz., April 04, 2022 (GLOBE NEWSWIRE) — Journey Medical Corporation (“Journey Medical”) (NADSAQ: DERM),…
CorMedix Inc. to Present at the 21st Annual Needham Virtual Healthcare Conference
BERKELEY HEIGHTS, N.J., April 04, 2022 (GLOBE NEWSWIRE) — CorMedix Inc. (Nasdaq: CRMD), a biopharmaceutical…
Acer Therapeutics’ EDSIVO™ (celiprolol) Granted FDA Breakthrough Therapy Designation for Vascular Ehlers-Danlos Syndrome
Discussions ongoing with FDA through special protocol assessment (SPA) seeking agreement on planned pivotal Phase…